Michael D. Clayman
Overview
Michael D. Clayman received an average of $3M in total compensation, including $516K in salary, at Flexion Therapeutics from 2014 to 2018.
2018Flexion TherapeuticsPresident, CEO and Co-Founder
2017Flexion TherapeuticsPresident, CEO and Co-Founder
2016Flexion TherapeuticsPresident, Chief Executive Officer and Co-Founder
2015Flexion TherapeuticsPresident, Chief Executive Officer and Co-Founder
2014Flexion TherapeuticsPresident, CEO and Co-Founder
Source: SEC filings on April 26, 2019, April 26, 2018, April 28, 2017, and April 26, 2016.
Related executives
We found six more executives who work or worked at Flexion Therapeutics.
David Arkowitz
Flexion Therapeutics
Chief Financial Officer
Neil Bodick
Flexion Therapeutics
Chief Scientific Officer
Mark Levine
Flexion Therapeutics
General Counsel
Scott Kelly
Flexion Therapeutics
Chief Medical Officer
Yamo Deniz
Flexion Therapeutics
Chief Medical Officer
Frederick Driscoll
Flexion Therapeutics